AltRx Tirzepatide Cost: Promotional Pricing Through September 2026

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

AltRx advertises compounded tirzepatide injection at promotional rates ranging from $149/month (month-to-month) down to $125/month (12-month prepaid = $1,500 upfront) through September 5, 2026. The promotional grid includes medical oversight, medication, support, and shipping with no separate membership fee. However, standard post-promotion pricing is not disclosed in publicly accessible materials or intake flows captured September 4, 2026, and individual Trustpilot and Reddit reports allege unexpected annual prebilling despite selecting month-to-month options. Without documented ongoing rates beyond the promotional deadline, readers evaluating AltRx after early September 2026 should confirm current pricing and billing terms at checkout.

AltRx tirzepatide promotional pricing at-a-glance

Source: AltRx public website and intake flow, captured September 4, 2026. Promotional pricing ends September 5, 2026; post-promotion rates not documented.

Breaking down the promotional structure

AltRx's tirzepatide promotional grid offers four duration tiers, all ending September 5, 2026. The advertised monthly-equivalent rate drops as prepayment commitment increases: $149/month for month-to-month service, down to $125/month when paying $1,500 upfront for a full year. Multi-month rates require the full period paid in advance—$255 every three months, $780 every six months, or $1,500 annually—making them prepaid per-month equivalents rather than true monthly billing.

All promotional tiers include medical oversight, compounded tirzepatide medication, support, and shipping with no separate membership or consultation fee. The platform advertises same-price dosing across all strength tiers, meaning a patient titrating from 2.5 mg to 10 mg pays the same monthly rate within a given plan duration.

The post-promotion pricing gap

AltRx's public website, FAQ, and intake flow captured September 4, 2026 do not disclose standard ongoing rates that apply after the September 5, 2026 promotional deadline. A reader signing up on September 6, 2026 or later would encounter pricing at checkout that is not documented in publicly accessible materials reviewed for this analysis. This absence means we cannot calculate a durable 12-month cost for patients starting or renewing beyond early September 2026.

Normalized 12-month cost comparison

Because AltRx's captured rates are time-limited promotional figures ending September 5, 2026, the following 12-month projections apply only to enrollments completed during the promotional window. Readers evaluating AltRx after that date should confirm current pricing directly.

AltRx figures valid through September 5, 2026 only; post-promotion rates unknown. PlexusDx rates are standard ongoing prices, not promotional. All PlexusDx commitments bill monthly; prepayment is never required.

During the promotional window, AltRx's 12-month prepaid plan ($1,500 total, $125/month equivalent) runs $1,488 below PlexusDx's 6-month commitment over the same 12-month span. The promotional 1-month plan ($1,788 annually) saves $1,680 compared to PlexusDx month-to-month. However, AltRx's longer-term tiers require the full period paid upfront—$1,500 for the annual plan—while PlexusDx bills monthly regardless of commitment length, requiring only the first month's payment to start.

Reported billing concerns and cancellation policy

AltRx advertises "cancel anytime" flexibility alongside its promotional pricing. However, individual Trustpilot and Reddit reports captured September 4, 2026 allege unexpected full-year prebilling despite the customer selecting a month-to-month option at signup. One Trustpilot reviewer reported a one-star experience claiming the entire annual amount was charged upfront even though the monthly plan was chosen. A separate Reddit thread described a similar allegation.

These are individual customer reports and allegations, not verified facts, and they conflict with AltRx's advertised cancellation flexibility. Because our intake verification stopped before payment submission, we cannot confirm the checkout billing flow or whether the reports reflect a technical error, user misunderstanding, or broader billing practice. Readers should review the payment summary carefully at checkout and confirm the charged amount matches the selected plan duration before completing enrollment.

Same-dose pricing and inclusions

AltRx advertises the same promotional rate at all tirzepatide dose levels, meaning a patient starting at 2.5 mg weekly and a patient maintaining at 10 mg weekly both pay $149/month on the 1-month plan (or the corresponding rate on longer prepaid tiers). The promotional rate includes the provider visit, prescription, compounded medication, ongoing support, and shipping—no separate membership, consultation, or delivery fees are listed.

Compounded tirzepatide is prepared by a compounding pharmacy and is not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Choose AltRx if…

• You are enrolling before September 5, 2026 and want to lock in a promotional tirzepatide rate that runs well below standard market pricing during the promotional period.
• You are comfortable prepaying $1,500 upfront for a full year to secure the lowest advertised monthly-equivalent rate ($125/month).
• You accept the uncertainty of post-promotion renewal pricing, which is not disclosed in materials captured September 4, 2026.
• You will carefully review the payment summary at checkout to confirm the charged amount matches your selected plan, given individual reports alleging unexpected annual prebilling.

Where PlexusDx fits

PlexusDx compounded tirzepatide injection runs $289/month month-to-month, $269/month with a 3-month commitment, and $249/month with a 6-month commitment—rates that apply year-round with no promotional windows or renewal surprises. Every tier bills monthly; prepayment is never required, even on the 6-month commitment. The program includes the provider visit, prescription, compounded tirzepatide, care-team support, and shipping in one flat rate with no membership or consultation fees.

PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician reviews your intake and determines whether tirzepatide is appropriate for your individual situation. Dose adjustments follow the same published monthly rate—no tier-based pricing or upcharges as you titrate. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

If you prioritize locked-in pricing that never changes month to month, transparent billing with no prepayment requirement, and a service model where the published rate is the rate you pay every refill, PlexusDx tirzepatide offers a durable alternative to time-limited promotional structures.

Methodology and freshness

This analysis draws on AltRx's public website, promotional landing pages, and intake flow captured September 4, 2026. We completed intake verification through the promotional pricing grid but stopped before payment submission; prepayment requirements for multi-month tiers are inferred from the pricing presentation and labeled as such. Individual Trustpilot and Reddit billing reports were captured September 4, 2026 and are presented as allegations, not verified facts. All 12-month cost projections are our calculations based on the advertised promotional rates; AltRx does not publish annual totals. PlexusDx pricing reflects standard published rates current as of September 15, 2026. Post-promotion AltRx tirzepatide pricing is not documented; readers evaluating AltRx after September 5, 2026 should confirm current rates directly at checkout.

Frequently Asked Questions

What is AltRx's tirzepatide cost after the September 2026 promotion ends?

AltRx's standard ongoing tirzepatide rates are not disclosed in publicly accessible materials or intake flows captured September 4, 2026. The promotional grid ending September 5, 2026 advertises rates from $149/month (1-month) down to $125/month (12-month prepaid). Post-promotion pricing should be confirmed at checkout if you are enrolling after early September 2026.

Does AltRx require prepayment for tirzepatide plans?

The promotional pricing structure infers prepayment for 3-month ($255 upfront), 6-month ($780 upfront), and 12-month ($1,500 upfront) tiers, though this was not checkout-verified. The 1-month plan appears to bill $149 monthly. Individual reports allege unexpected annual prebilling even when selecting month-to-month options; review your payment summary carefully before completing enrollment.

Are there extra fees beyond AltRx's advertised tirzepatide rate?

AltRx's promotional rates include medical oversight, compounded tirzepatide medication, support, and shipping with no separate membership or consultation fee listed in materials captured September 4, 2026. Confirm at checkout that no additional charges appear before submitting payment, and verify the total matches your selected plan duration.

Does the AltRx tirzepatide price change as my dose increases?

AltRx advertises the same promotional rate at all tirzepatide dose levels—2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg all carry the same monthly cost within a given plan duration. This same-dose pricing applies during the promotional period ending September 5, 2026; confirm whether it continues under post-promotion standard rates.

How does AltRx promotional tirzepatide pricing compare to PlexusDx year-round rates?

AltRx's promotional 12-month prepaid plan ($1,500 total, $125/month equivalent) runs $1,488 below PlexusDx's 6-month commitment over 12 months, but requires $1,500 upfront and ends September 5, 2026 with unknown renewal pricing. PlexusDx tirzepatide runs $289/month month-to-month or $249/month on a 6-month commitment, billed monthly year-round with no prepayment and no promotional expiration.

Sources

• AltRx promotional pricing grid and intake flow, accessed September 4, 2026
• AltRx public website FAQ and plan details, accessed September 4, 2026
• Trustpilot individual customer review (billing allegation), accessed September 4, 2026
• Reddit discussion thread (billing allegation), accessed September 4, 2026
• PlexusDx tirzepatide injection product page and published pricing, accessed September 15, 2026
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com), accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.